Good afternoon :)
Place Order
Add to Watchlist

Advanced Enzyme Technologies Ltd

ADVENZYMES Share Price

308.701.69% (-5.30)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹3,514 cr, stock is ranked 929

Stock is 2.91x as volatile as Nifty

ADVENZYMES Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹3,514 cr, stock is ranked 929

Stock is 2.91x as volatile as Nifty

ADVENZYMES Performance & Key Metrics

ADVENZYMES Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
23.852.391.66%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
27.823.181.63%

ADVENZYMES Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

ADVENZYMES Company Profile

Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.

Investor Presentation

View older View older 

Nov 12, 2025

PDF
View Older Presentations

ADVENZYMES Similar Stocks (Peers)

Compare with peers Compare with peers 

ADVENZYMES Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
67.36
67.36
1Y Return
17.58%
17.58%
Buy Reco %
63.64
63.64
PE Ratio
102.36
102.36
1Y Return
60.47%
60.47%
Buy Reco %
69.57
69.57
PE Ratio
40.13
40.13
1Y Return
16.26%
16.26%
Buy Reco %
75.00
75.00
PE Ratio
37.55
37.55
1Y Return
4.62%
4.62%
Buy Reco %
100.00
100.00
PE Ratio
152.64
152.64
1Y Return
69.68%
69.68%
Buy Reco %
42.86
42.86
Compare with Peers

ADVENZYMES Sentiment Analysis

ADVENZYMES Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

ADVENZYMES Stock Summary · August 2025

In Q1 FY '26, the company achieved a remarkable 20% year-on-year revenue growth, driven primarily by strong performance in the Human and Animal Healthcare segments, despite facing challenges from tariffs and competitive pricing pressures that have impacted gross margins. The establishment of a new subsidiary in the nutrition and wellness sector reflects a strategic pivot towards consumer products, while ongoing R&D investments underscore a commitment to innovation, particularly in biocatalysis. However, management remains cautious about future growth, emphasizing the need for a distinct strategy in the B2C market and the importance of navigating complex market dynamics. As the company aims for 80% capacity utilization within two years, it is also addressing the challenges of converting patent interest into tangible sales, particularly in the European market. Overall, while optimism persists regarding growth opportunities, the landscape remains fraught with uncertainties that could influence operational performance.

ADVENZYMES Stock Growth Drivers
ADVENZYMES Stock Growth Drivers
7
  • Strong Financial Performance

    The company reported its highest-ever quarterly revenue of INR 185.9 crores (INR 1,859 million) for

  • Segment Growth and Diversification

    The Human Healthcare and Animal Healthcare segments drove robust performance, with the Animal Healthcare segment

ADVENZYMES Stock Challenges
ADVENZYMES Stock Challenges
5
  • Decline in EBITDA Margins

    The company has experienced a significant decline in EBITDA margins, which have decreased from over

  • Challenges in Gross Margins

    Gross margins have decreased from historically high levels of over 75% to around 72-73% due

ADVENZYMES Forecast

ADVENZYMES Forecasts

Price

Revenue

Earnings

ADVENZYMES

ADVENZYMES

Income

Balance Sheet

Cash Flow

ADVENZYMES Income Statement

ADVENZYMES Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.3%, vs industry avg of 11.01%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.84% to 0.68%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 0.28%, vs industry avg of 7.61%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue331.57392.41424.63449.63510.69535.80566.10660.53669.95742.29
Raw Materialssubtract70.1480.3365.9590.83100.21130.32127.53155.47161.96489.39
Power & Fuel Costsubtract12.8718.1019.2919.3721.4529.9538.1041.5138.45
Employee Costsubtract50.7068.6080.2380.1987.11103.96114.80127.78141.54
Selling & Administrative Expensessubtract25.6138.4140.0437.5837.7251.8056.2259.9664.17
Operating & Other expensessubtract18.0020.6430.8412.6522.7810.7750.5648.6335.28
Depreciation/Amortizationsubtract12.7618.3021.1225.7828.7234.9835.0335.2436.5638.75
Interest & Other Itemssubtract4.439.065.204.082.572.963.484.124.633.23
Taxes & Other Itemssubtract45.5148.9150.9049.8764.2151.4834.7554.5256.2663.54
EPS2.798.079.9511.5813.0610.709.4511.9211.7213.17
DPS0.080.500.600.600.901.001.005.105.205.20
Payout ratio0.030.060.060.050.070.090.110.430.440.39

ADVENZYMES Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

Nov 12PDF
Sep 22PDF
Aug 2PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 13PDF
Feb 8PDF
Nov 9PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 12PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 13PDF
Feb 11PDF
Nov 11PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

ADVENZYMES Stock Peers

ADVENZYMES Past Performance & Peer Comparison

ADVENZYMES Past Performance & Peer Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Advanced Enzyme Technologies Ltd26.812.391.66%
Gujarat Fluorochemicals Ltd67.365.040.09%
Navin Fluorine International Ltd102.3611.250.12%
Vinati Organics Ltd40.135.820.48%

ADVENZYMES Stock Price Comparison

Compare ADVENZYMES with any stock or ETF
Compare ADVENZYMES with any stock or ETF
ADVENZYMES
Loading...

ADVENZYMES Holdings

ADVENZYMES Shareholdings

ADVENZYMES Promoter Holdings Trend

ADVENZYMES Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ADVENZYMES Institutional Holdings Trend

ADVENZYMES Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has increased by 1.96%

Tickertape Separator

ADVENZYMES Shareholding Pattern

ADVENZYMES Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding43.07%3.24%3.17%25.41%25.10%

Dec 2024

Mar 2025

Jun 2025

Sep 2025

ADVENZYMES Shareholding History

ADVENZYMES Shareholding History

JunSepDec '24MarJunSep12.03%12.63%12.58%11.90%23.46%25.41%

Mutual Funds Invested in ADVENZYMES

Mutual Funds Invested in ADVENZYMES

No mutual funds holding trends are available

Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
0.1443%0.19%-0.03%91/295 (+3)
0.0596%0.12%0.12%118/144 (-99)
0.0007%0.01%-0.00%646/795 (+1)

Compare 3-month MF holding change on Screener

ADVENZYMES Insider Trades & Bulk Stock Deals

ADVENZYMES Insider Trades & Bulk Stock Deals

Loading...

smallcases containing ADVENZYMES stock

smallcases containing ADVENZYMES stock

Looks like this stock is not in any smallcase yet.

ADVENZYMES Events

ADVENZYMES Events

ADVENZYMES Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ADVENZYMES has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.55 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ADVENZYMES Dividend Trend

No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year

ADVENZYMES has increased or maintained dividend levels over the last 5 years

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 1.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.55 every year

ADVENZYMES Upcoming Dividends

ADVENZYMES Upcoming Dividends

No upcoming dividends are available

ADVENZYMES Past Dividends

ADVENZYMES Past Dividends

Cash Dividend

Ex DateEx DateJul 23, 2025

Final
Final | Div/Share: ₹1.20

Dividend/Share

1.20

Ex DateEx Date

Jul 23, 2025

Cash Dividend

Ex DateEx DateMay 16, 2025

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 16, 2025

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹1.10

Dividend/Share

1.10

Ex DateEx Date

Jul 18, 2024

Cash Dividend

Ex DateEx DateMay 17, 2024

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

4.00

Ex DateEx Date

May 17, 2024

Cash Dividend

Ex DateEx DateAug 4, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Aug 4, 2023

ADVENZYMES Stock News & Opinions

ADVENZYMES Stock News & Opinions

Spotlight
Advanced Enzyme surges after strong Q2 performance

Total expenditure for the period under review added up to Rs 135.27 crore, up 19.2% YoY. This was primarily due to higher raw material costs (up 24.8% YoY), higher employee expenses (up 10.8% YoY) and higher other expenses (up 14.3% YoY). Profit before tax in Q2 FY26 stood at Rs 59.54 crore, up by 41% from Rs 42.21 crore recorded in Q2 FY25. Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions. Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit rises 31.98% in the September 2025 quarter

Net profit of Advanced Enzyme Technologies rose 31.98% to Rs 43.33 crore in the quarter ended September 2025 as against Rs 32.83 crore during the previous quarter ended September 2024. Sales rose 26.30% to Rs 184.53 crore in the quarter ended September 2025 as against Rs 146.10 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales184.53146.10 26 OPM %32.5529.03 - PBDT69.6251.10 36 PBT59.5442.21 41 NP43.3332.83 32 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to hold board meeting

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live

4 weeks agoCapital Market - Live
Corporate
Advanced Enzyme Technologies allots 45,650 equity shares under ESOP

Advanced Enzyme Technologies has allotted 45,650 equity shares under ESOP. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each to Rs 22,38,53,600 comprising of 11,19,26,800 equity shares of Rs 2 each. Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Advanced Enzyme Technologies Ltd leads gainers in 'A' group

Relaxo Footwears Ltd, Apollo Micro Systems Ltd, Granules India Ltd and Godfrey Phillips India Ltd are among the other gainers in the BSE's 'A' group today, 29 August 2025.Advanced Enzyme Technologies Ltd spiked 8.42% to Rs 351.5 at 11:45 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 9.8 lakh shares were traded on the counter so far as against the average daily volumes of 62622 shares in the past one month. Relaxo Footwears Ltd surged 7.06% to Rs 478.95. The stock was the second biggest gainer in 'A' group. On the BSE, 1.05 lakh shares were traded on the counter so far as against the average daily volumes of 35687 shares in the past one month. Apollo Micro Systems Ltd soared 6.93% to Rs 259.3. The stock was the third biggest gainer in 'A' group. On the BSE, 36.02 lakh shares were traded on the counter so far as against the average daily volumes of 12.89 lakh shares in the past one month. Granules India Ltd rose 6.85% to Rs 499.35. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.79 lakh shares were traded on the counter so far as against the average daily volumes of 70472 shares in the past one month. Godfrey Phillips India Ltd gained 6.42% to Rs 11276.5. The stock was the fifth biggest gainer in 'A' group. On the BSE, 66205 shares were traded on the counter so far as against the average daily volumes of 55906 shares in the past one month. Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Advanced Enzyme Technologies Ltd leads losers in 'A' group

Shakti Pumps (India) Ltd, Neogen Chemicals Ltd, Balaji Amines Ltd and Thermax Ltd are among the other losers in the BSE's 'A' group today, 04 August 2025.Advanced Enzyme Technologies Ltd crashed 8.54% to Rs 329.5 at 14:46 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 92278 shares were traded on the counter so far as against the average daily volumes of 32674 shares in the past one month.Shakti Pumps (India) Ltd tumbled 6.78% to Rs 832.95. The stock was the second biggest loser in 'A' group.On the BSE, 3.43 lakh shares were traded on the counter so far as against the average daily volumes of 47449 shares in the past one month.Neogen Chemicals Ltd lost 6.35% to Rs 1439.85. The stock was the third biggest loser in 'A' group.On the BSE, 3976 shares were traded on the counter so far as against the average daily volumes of 1365 shares in the past one month.Balaji Amines Ltd plummeted 6.28% to Rs 1584.7. The stock was the fourth biggest loser in 'A' group.On the BSE, 14808 shares were traded on the counter so far as against the average daily volumes of 7595 shares in the past one month.Thermax Ltd shed 6.01% to Rs 3549.7. The stock was the fifth biggest loser in 'A' group.On the BSE, 7331 shares were traded on the counter so far as against the average daily volumes of 14343 shares in the past one month.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit rises 16.93% in the June 2025 quarter

Net profit of Advanced Enzyme Technologies rose 16.93% to Rs 39.93 crore in the quarter ended June 2025 as against Rs 34.15 crore during the previous quarter ended June 2024. Sales rose 20.31% to Rs 185.91 crore in the quarter ended June 2025 as against Rs 154.52 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales185.91154.52 20 OPM %30.3533.12 - PBDT64.5257.29 13 PBT54.9048.67 13 NP39.9334.15 17 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to announce Quarterly Result

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 2 August 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Advanced Enzyme Technologies fixes record date for interim dividend

Advanced Enzyme Technologies has fixed 17 May 2025 as record date for payment of interim dividend of Rs 4 per equity share for FY 2025-26. The dividend will be paid on or before 10 June 2025. Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to convene AGM

Advanced Enzyme Techs. announced that the 36th Annual General Meeting(AGM) of the company will be held on 30 July 2025.Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Advanced Enzyme Technologies Ltd (ADVENZYMES) today?

    The share price of ADVENZYMES as on 5th December 2025 is ₹308.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The past returns of Advanced Enzyme Technologies Ltd (ADVENZYMES) share are
    • Past 1 week: -0.49%
    • Past 1 month: -1.82%
    • Past 3 months: -8.20%
    • Past 6 months: 2.08%
    • Past 1 year: -15.96%
    • Past 3 years: 10.72%
    • Past 5 years: -10.31%

  3. What are the peers or stocks similar to Advanced Enzyme Technologies Ltd (ADVENZYMES)?
  4. What is the dividend yield % of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The current dividend yield of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 1.66.

  5. What is the market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹3514.50 Cr as of 5th December 2025.

  6. What is the 52 week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) share?

    The 52-week high of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹411.40 and the 52-week low is ₹257.90.

  7. What is the PE and PB ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) stock?

    The P/E (price-to-earnings) ratio of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 26.81. The P/B (price-to-book) ratio is 2.39.

  8. Which sector does Advanced Enzyme Technologies Ltd (ADVENZYMES) belong to?

    Advanced Enzyme Technologies Ltd (ADVENZYMES) belongs to the Materials sector & Specialty Chemicals sub-sector.

  9. How to buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares?

    You can directly buy Advanced Enzyme Technologies Ltd (ADVENZYMES) shares on Tickertape. Simply sign up, connect your demat account and place your order.